These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28177671)

  • 1. The effect of short-term oral treatment with omeprazole or pantoprazole on the function of polymorphonuclear neutrophils.
    Kostrzewska M; Garley M; Ratajczak-Wrona W; Jabłońska E; Jamiołkowski J; Dabrowski A
    Can J Physiol Pharmacol; 2017 Jun; 95(6):675-680. PubMed ID: 28177671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of p38 MAPK pathway in induction of iNOS expression in neutrophils and peripheral blood mononuclear cells in patients with squamous cell carcinoma of the oral cavity.
    Ratajczak-Wrona W; Jablonska E; Marcinczyk M; Grabowska Z; Piotrowski L
    J Oral Maxillofac Surg; 2009 Nov; 67(11):2354-63. PubMed ID: 19837302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of N-nitrosodimethylamine on inducible nitric oxide synthase expression and production of nitric oxide by neutrophils and mononuclear cells: the role of JNK signalling pathway.
    Ratajczak-Wrona W; Jablonska E; Garley M; Jablonski J; Radziwon P
    APMIS; 2011 Jul; 119(7):431-41. PubMed ID: 21635550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitory effects of H+ K+ ATPase inhibitors on human neutrophils in vitro: restoration by a K+ ionophore.
    Martins de Oliveira R; Antunes E; Pedrazzoli J; Gambero A
    Inflamm Res; 2007 Mar; 56(3):105-11. PubMed ID: 17406807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of MAP kinases in the induction of iNOS expression in neutrophils exposed to NDMA: the involvement transcription factors.
    Ratajczak-Wrona W; Jablonska E; Garley M; Jablonski J; Radziwon P; Iwaniuk A
    Adv Med Sci; 2013; 58(2):265-73. PubMed ID: 23981673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ERK1/2 kinase in the expression of iNOS by NDMA in human neutrophils.
    Ratajczak-Wrona W; Jablonska E; Garley M; Jablonski J; Radziwon P
    Indian J Exp Biol; 2013 Jan; 51(1):73-80. PubMed ID: 23441482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pantoprazole treatment does not invoke anti-inflammatory properties in vivo.
    Becker TL; Maróstica M; Ribeiro ML; de Mendonça S; Gambero A; Pedrazzoli J
    Int Immunopharmacol; 2004 Aug; 4(8):1051-7. PubMed ID: 15222979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Jun N-terminal kinase and p38 mitogen-activated protein kinase mediate double-strand RNA-induced inducible nitric oxide synthase expression in microglial cells.
    Kong PJ; Lee HJ; Lee SH; Kim SY; Lee SN; Chun WJ; Kim SS
    Neurosci Lett; 2008 Mar; 433(3):215-8. PubMed ID: 18258363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors omeprazole, lansoprazole and pantoprazole induce relaxation in the rat lower oesophageal sphincter.
    Yurtsever AS; Pektas M; Ozkur M; Un I; Erenmemisoglu A; Buyukafsar K
    J Pharm Pharmacol; 2011 Oct; 63(10):1295-300. PubMed ID: 21899545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of p38 mitogen-activated protein kinase in lipopolysaccharide-induced expression of inducible nitric oxide synthase in human endothelial cells.
    Kan WH; Yan WS; Jiang Y; Wang JZ; Qin QH; Zhao KS
    Di Yi Jun Yi Da Xue Xue Bao; 2002 May; 22(5):388-92. PubMed ID: 12390692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study.
    Cuisset T; Frere C; Quilici J; Poyet R; Gaborit B; Bali L; Brissy O; Morange PE; Alessi MC; Bonnet JL
    J Am Coll Cardiol; 2009 Sep; 54(13):1149-53. PubMed ID: 19761935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pantoprazole does not influence the antiplatelet effect of clopidogrel-a whole blood aggregometry study after coronary stenting.
    Neubauer H; Engelhardt A; Krüger JC; Lask S; Börgel J; Mügge A; Endres HG
    J Cardiovasc Pharmacol; 2010 Jul; 56(1):91-7. PubMed ID: 20410834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of p38 mitogen-activated protein kinase enhances c-Jun N-terminal kinase activity: implication in inducible nitric oxide synthase expression.
    Lahti A; Sareila O; Kankaanranta H; Moilanen E
    BMC Pharmacol; 2006 Feb; 6():5. PubMed ID: 16504051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. iNOS expression and NO production by neutrophils in cancer patients.
    Jabłońska E; Puzewska W; Marcińczyk M; Grabowska Z; Jabłoński J
    Arch Immunol Ther Exp (Warsz); 2005; 53(2):175-9. PubMed ID: 15928587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR
    Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies.
    Angiolillo DJ; Gibson CM; Cheng S; Ollier C; Nicolas O; Bergougnan L; Perrin L; LaCreta FP; Hurbin F; Dubar M
    Clin Pharmacol Ther; 2011 Jan; 89(1):65-74. PubMed ID: 20844485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.
    Castell D; Bagin R; Goldlust B; Major J; Hepburn B
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1467-74. PubMed ID: 15948814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BUDGET IMPACT ANALYSIS OF USING OMEPRAZOLE IMMEDIATE-RELEASE ORAL SUSPENSION IN REPLACE OF INTRAVENOUS PANTOPRAZOLE IN CRITICALLY ILL PATIENTS.
    Foroutan N; Fahimi F; Dabiri Y; Foroutan A; Habibi M; Salamzadeh J
    J Popul Ther Clin Pharmacol; 2015 Dec; 22(3):e292-e302. PubMed ID: 28414416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.
    Röhss K; Lind T; Wilder-Smith C
    Eur J Clin Pharmacol; 2004 Oct; 60(8):531-9. PubMed ID: 15349707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative chronotropic effect of proton pump inhibitors on frog-heart preparation.
    Gautam CS; Utreja A; Goel D; Sandhu G; Gogia N
    Indian J Gastroenterol; 2009; 28(4):147-9. PubMed ID: 19937171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.